Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
75,239 questions in 5,342 reviews
current versionsNo studies 15,213 · 20.2%Ungraded 10,323 · 13.7%Very low 17,528 · 23.3%Low 17,951 · 23.9%Moderate 11,190 · 14.9%High 3,034 · 4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Summary of findings table ‐ Antibiotics vs placebo or no intervention Serious adverse events ‐ not reported · farmworkers, soldiers, and people in endemic areas Antibiotic prophylaxis for leptospirosis (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Antibiotics vs placebo or no intervention Quality of life ‐ not reported · farmworkers, soldiers, and people in endemic areas Antibiotic prophylaxis for leptospirosis (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Antibiotics vs placebo or no intervention Non‐serious adverse events · farmworkers, soldiers, and people in endemic areas Antibiotic prophylaxis for leptospirosis (2024) · Cochrane | RR 10.13 [2.4, 42.71] | 3 studies · 1909 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics All‐cause mortality ‐ not reported · farmworkers Antibiotic prophylaxis for leptospirosis (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Antibiotics vs other antibiotics Laboratory‐confirmed leptospirosis · farmworkers Antibiotic prophylaxis for leptospirosis (2024) · Cochrane | RR 1.53 [0.53, 4.45] | 1 study · 137 participants | Very low |
Summary of findings table ‐ Antibiotics vs placebo or no intervention All‐cause mortality · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 1.57 [0.65, 3.79] | 3 studies · 367 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics Adverse events considered non‐serious (penicillin versus cefotaxime) · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 3.03 [0.13, 73.47] | 1 study · 175 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics Adverse events considered non‐serious (penicillin versus doxycycline) · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 2.8 [0.12, 67.66] | 1 study · 168 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics Adverse events considered non‐serious (penicillin versus chloramphenicol) · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 0.74 [0.15, 3.67] | 1 study · 52 participants | Very low |
Summary of findings table ‐ Antibiotics vs placebo or no intervention Serious adverse event ‐ not reported · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Antibiotics vs placebo or no intervention Adverse events considered non‐serious · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 1.05 [0.35, 3.17] | 2 studies · 162 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics All‐cause mortality (penicillin versus a cephalosporin (cefotaxime or ceftriaxone)) · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 1.38 [0.47, 4.04] | 2 studies · 348 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics All‐cause mortality (penicillin versus doxycycline) · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 0.93 [0.13, 6.46] | 1 study · 168 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics All‐cause mortality (a cephalosporin (cefotaxime) versus doxycycline) · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 0.18 [0.01, 3.78] | 1 study · 169 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics Serious adverse events (nosocomial infection) (penicillin versus cefotaxime) · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 1.01 [0.15, 7.02] | 1 study · 175 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics Serious adverse events (nosocomial infection) (penicillin versus doxycycline) · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 0.62 [0.11, 3.62] | 1 study · 168 participants | Very low |
Summary of findings table ‐ Antibiotics vs other antibiotics Serious adverse events (nosocomial infection) (doxycycline versus cefotaxime) · people with leptospirosis Antibiotics for treatment of leptospirosis (2024) · Cochrane | RR 1.01 [0.15, 7.02] | 1 study · 175 participants | Very low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Billroth II reconstruction after distal gastrectomy Health‐related quality of life ‐ not reported · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Roux‐en‐Y reconstruction after distal gastrectomy Incidence of anastomotic leakage · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | RR 0.34 [0.05, 2.08] | 2 studies · 213 participants | Very low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Roux‐en‐Y reconstruction after distal gastrectomy Changes in body weight from baseline ‐ not reported · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Roux‐en‐Y reconstruction after distal gastrectomy Incidence of bile reflux · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | RR 10.74 [3.52, 32.76] | 1 study · 108 participants | Very low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Roux‐en‐Y reconstruction after distal gastrectomy Incidence of remnant gastritis · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | RR 1.18 [0.69, 2.01] | 3 studies · 361 participants | Very low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Roux‐en‐Y reconstruction after distal gastrectomy Incidence of oesophagitis · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | RR 0.82 [0.53, 1.26] | 3 studies · 361 participants | Very low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Billroth II reconstruction after distal gastrectomy Major postoperative complications · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | RR 0.98 [0.24, 4.05] | 2 studies · 282 participants | Very low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Billroth II reconstruction after distal gastrectomy Incidence of anastomotic leakage · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | RR 0.64 [0.29, 1.44] | 3 studies · 615 participants | Very low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Billroth II reconstruction after distal gastrectomy Changes in body weight from baseline · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | no estimate extracted | 2 studies · 233 participants | Low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Billroth II reconstruction after distal gastrectomy Incidence of bile reflux · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | RR 0.67 [0.55, 0.83] | 1 study · 141 participants | Low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Billroth II reconstruction after distal gastrectomy Incidence of remnant gastritis · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | RR 0.27 [0.01, 5.06] | 2 studies · 265 participants | Very low |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Billroth II reconstruction after distal gastrectomy Incidence of oesophagitis ‐ not reported · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Roux‐en‐Y reconstruction after distal gastrectomy Health‐related quality of life ‐ not reported · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Uncut Roux‐en‐Y reconstruction vs Roux‐en‐Y reconstruction after distal gastrectomy Major postoperative complications · people undergoing distal gastrectomy for gastric cancer Uncut Roux‐en‐Y reconstruction after distal gastrectomy for gastric cancer (2024) · Cochrane | RR 4.74 [0.23, 97.08] | 2 studies · 256 participants | Very low |
Intervention NR Transmission‐related outcomes: cases‐ number or proportion of cases Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Moderate |
Intervention NR Transmission‐related outcomes: cases ‐ risk of infection Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Transmission‐related outcomes: cases‐ number or proportion of cases Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Moderate |
Intervention NR Intended and unintended consequences: social and institutional consequences ‐ days of absences avoided Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Moderate |
Intervention NR PPV Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Proportion of cases detected Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Onward transmission (secondary and tertiary transmission) Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Transmission‐related outcomes: cases ‐ risk of infection Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Transmission‐related outcomes: cases ‐ number or proportion of cases Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Moderate |
Intervention NR Transmission‐related outcomes: cases ‐ epidemic progression Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Transmission‐related outcomes: cases ‐ risk of infection Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Transmission‐related outcomes: cases: risk of infection Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Very low |
Intervention NR Transmission‐related outcomes: deaths ‐ number and proportion of deaths Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Moderate |
Intervention NR Transmission‐related outcomes: hospitalization ‐ number or proportion of hospital admissions Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Moderate |
Intervention NR Transmission‐related outcomes: hospitalization ‐ Number or proportion of hospital admissions Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Moderate |
Intervention NR Transmission‐related outcomes: cases ‐ number or proportion of cases Measures implemented in the school setting to contain the COVID‐19 pandemic (2024) · Cochrane | no estimate extracted | NR | Moderate |
Antibiotics vs surgery Mortality · adults with uncomplicated appendicitis Appendectomy versus antibiotic treatment for acute appendicitis (2024) · Cochrane | OR 0.51 [0.05, 4.95] | 5 studies · 2377 participants | Very low |
Antibiotics vs surgery Success of treatment · adults with uncomplicated appendicitis Appendectomy versus antibiotic treatment for acute appendicitis (2024) · Cochrane | RR 0.91 [0.87, 0.96] | 7 studies · 2471 participants | Low |
Antibiotics vs surgery Appendectomy in the antibiotic group · adults with uncomplicated appendicitis Appendectomy versus antibiotic treatment for acute appendicitis (2024) · Cochrane | no estimate extracted | 9 studies · 1396 participants | Very low |